ATE70561T1 - Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin. - Google Patents

Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin.

Info

Publication number
ATE70561T1
ATE70561T1 AT87460013T AT87460013T ATE70561T1 AT E70561 T1 ATE70561 T1 AT E70561T1 AT 87460013 T AT87460013 T AT 87460013T AT 87460013 T AT87460013 T AT 87460013T AT E70561 T1 ATE70561 T1 AT E70561T1
Authority
AT
Austria
Prior art keywords
culture
rhinotracheitis virus
virus
production
vaccine prepared
Prior art date
Application number
AT87460013T
Other languages
English (en)
Inventor
Patrick Giraud
Georges Bennejean
Michele Guittet
Didier Toquin
Original Assignee
Ministere De L Agriculture Dir
Rhone Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ministere De L Agriculture Dir, Rhone Merieux filed Critical Ministere De L Agriculture Dir
Application granted granted Critical
Publication of ATE70561T1 publication Critical patent/ATE70561T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18361—Methods of inactivation or attenuation
    • C12N2760/18364—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT87460013T 1986-08-18 1987-07-16 Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin. ATE70561T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8611872A FR2602791B1 (fr) 1986-08-18 1986-08-18 Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu
EP87460013A EP0263048B1 (de) 1986-08-18 1987-07-16 Verfahren zur Kultur des Virus der Rhinotracheitis des Truthahnes und daraus hergestelltes Vakzin

Publications (1)

Publication Number Publication Date
ATE70561T1 true ATE70561T1 (de) 1992-01-15

Family

ID=9338390

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87460013T ATE70561T1 (de) 1986-08-18 1987-07-16 Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin.

Country Status (7)

Country Link
US (1) US4810493A (de)
EP (1) EP0263048B1 (de)
AT (1) ATE70561T1 (de)
CA (1) CA1277270C (de)
DE (1) DE3775321D1 (de)
ES (1) ES2038689T3 (de)
FR (1) FR2602791B1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053732T3 (es) * 1987-05-21 1994-08-01 Know How Licensors Ltd Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
US5846805A (en) * 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US6080570A (en) * 1991-08-26 2000-06-27 Boehringer Ingelheim Vetmedica, Inc. Method of producing a vaccine for Swine Infertility and Respiratory Syndrome
US6982160B2 (en) 1991-08-26 2006-01-03 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions that include SIRS virus
CA2076744C (en) * 1991-08-26 2000-06-27 Danny W. Chladek Viral agent associated with mystery swine disease
US20040224327A1 (en) * 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0839912A1 (de) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Ansteckende Klone von RNA-Viren und darauf basierende Impfstoffe und diagnostisches Verfahren
WO2000053787A1 (en) 1999-03-08 2000-09-14 Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. Prrsv vaccines
DK1183332T3 (da) 1999-04-22 2010-09-06 Us Agriculture Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142
FR2801607B1 (fr) * 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
BRPI0510928A (pt) 2004-06-18 2007-11-13 Univ Minnesota identificação de organismos viralmente infectados e vacinados
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
UA95778C2 (ru) 2005-06-24 2011-09-12 Риджентс Оф Зе Юниверсити Оф Миннесота Вирусы репродуктивно-респираторного синдрома свиней, их инфекционные клоны и мутанты и способы применения
UA106475C2 (uk) * 2008-08-25 2014-09-10 Берингер Ингельхайм Ветмедика, Инк. Спосіб вакцинації свині проти високопатогенного репродуктивно-респіраторного синдрому свиней (hp prrs)
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
MY186535A (en) 2011-02-17 2021-07-26 Boehringer Ingelheim Vetmedica Gmbh Novel european prrsv strain
WO2012110490A1 (en) 2011-02-17 2012-08-23 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
US9315781B2 (en) 2011-07-29 2016-04-19 Boehringer Ingelheim Vetmedica Gmbh Infectious CDNA clone of european PRRS virus and uses thereof
EP2968513A2 (de) 2013-03-15 2016-01-20 Boehringer Ingelheim Vetmedica, Inc. Prrs-virus, zusammensetzungen, impfstoff und verfahren zur verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215107A (en) * 1978-12-29 1980-07-29 Merck & Co., Inc. Parainfluenza virus vaccine and its preparation
PT72077B (en) * 1979-11-30 1981-09-29 Gist Brocades Nv Infectious bronchitis vaccines for poultry and process forthe preparation of such vaccines
EP0073856A1 (de) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Impfstoff gegen ansteckende Bronchitis bei Geflügel, kombinierte Impfstoffe gegen ansteckende Bronchitis, Verfahren zu deren Herstellung, Verfahren zur Vorbeugung der ansteckenden Bronchitis und Virenstamm der ansteckenden Bronchitis

Also Published As

Publication number Publication date
CA1277270C (fr) 1990-12-04
FR2602791B1 (fr) 1988-11-10
EP0263048A1 (de) 1988-04-06
FR2602791A1 (fr) 1988-02-19
ES2038689T3 (es) 1993-08-01
EP0263048B1 (de) 1991-12-18
US4810493A (en) 1989-03-07
DE3775321D1 (de) 1992-01-30

Similar Documents

Publication Publication Date Title
ATE70561T1 (de) Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin.
KR0156732B1 (ko) 연속 셀 라인에서의 ibdv 생성
ATE286537T1 (de) Vakzinproduktion
HUP0102429A2 (hu) Baromfipestis-vírus fertőző klónjai, vakcinák és diagnosztikai eljárások
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
Pay et al. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process
ATE205536T1 (de) Mutanten von hepatitis a virus stamm hm-175 zur verwendung als hepatitis a virus impfstoffe
EP0101348A3 (de) Impfstoff gegen Geflügelproventriculitis, Geflügelproventriculitisreovirus, Verfahren zur Herstellung des Impfstoffes und Verfahren zum Schutz des Geflügels gegen Proventriculitis
ES553758A0 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
ES467557A1 (es) Un procedimiento para la preparacion de una nueva vacuna queprotege a las aves ponedoras de huevos contra la enfermedad del descenso de la produccion de huevos.
JPS55147227A (en) Preparrtion of attenuated live mumps vaccine
DE2962920D1 (en) Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
ES373631A1 (es) Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.
CZ659090A3 (en) Preparation for preparing antigens and process for preparing virus of early summer meningoencephalitis
ATE31733T1 (de) Verfahren zur herstellung von hybridisierungssonden.
ATE4441T1 (de) Verfahren zur herstellung von influenza-avirusimpfst[mmen, virusimpfstamm und diesen enthaltender impfstoff.
PL341724A1 (en) Mutated newcastle disease virus (ndv) and method of obtaining same, live or inactivated vaccine containing same and method of obtaining such vaccine
Igarashi A mutant of Chikungunya virus isolated from a line of Singh's Aedes albopictus cells by plaque formation on virus-sensitive cloned cells obtained from another Singh's A. albopictus cell line
WO1997027742B1 (en) Method of protein production using mitochondrial translation system
SE8700466L (sv) Vacciner mor melanom
GB1065875A (en) Measles vaccine attenuated through avian choric-allantoic membrane
RU2020136260A (ru) Живой аттенуированный штамм вируса желтой лихорадки, адаптированный к росту в клетках vero, и вакцинная композиция, содержащая его
BG61384B1 (bg) метод за получаване на жива атенуирана клетъчно-културална ваксина против псевдочума по птиците
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
ATE126702T1 (de) Verfahren zur herstellung von impfstoffen gegen rna-virus.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties